查看完整行情页>>

|

货币单位:美元(USD)

AcelRx Pharmaceuticals, Inc. (acrx)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Howard B. Rosen Howard B. Rosen is a businessperson who has been at the head of 5 different companies. He is Member of National Academy of Engineering and on the board of 6 other companies. In his past career Mr. Rosen held the position of Principal at Integral, Inc., Consultant at McKinsey & Co., Inc., Vice President-Commercial Strategy at Gilead Sciences, Inc., Chairman of Alcobra Ltd., President & Chief Executive Officer at Pearl Therapeutics, Inc., President at ALZA Corp. and Director-Corporate Development at GenPharm International, Inc. Mr. Rosen received an undergraduate degree from Stanford University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.
Richard F. Afable Richard F. Afable is a businessperson who has been at the head of 5 different companies is on the board of California Hospital Association (former Chairman), AcelRx Pharmaceuticals, Inc., Providence Little Co. of Mary Medical Institute and OnSite Waste Technologies, Inc. In the past Dr. Afable occupied the position of President & Chief Executive Officer of St. Joseph Hoag Health, Chief Executive Officer of Covenant Health Network, President & Chief Executive Officer for Hoag Hospital Foundation, Chief Medical Officer & Executive Vice President at Catholic Health East, President & Chief Executive Officer at Hoag Memorial Hospital Presbyterian, Inc., Professor at Wake Forest University and Professor at Northwestern University. Richard F. Afable received a doctorate and an undergraduate degree from Loyola University of Chicago and a graduate degree from the University of Illinois.
Mark Allen Wan Mark Allen Wan is an entrepreneur who founded 5 companies, including: Odyssey HealthCare, Inc., Epocrates LLC and Three Arch Partners. Currently, he is Managing Director at Causeway Management LLC (which he founded in 2013) and Managing Director at Three Arch Partners (which he founded in 2009), Managing Member at Three Arch Management IV LLC and Member of Three Arch Management LP (both are subsidiaries of Three Arch Partners). Mr. Wan is also Managing Member at Three Arch Management IV LLC and Member of Three Arch Management LP and on the board of 9 other companies. In his past career he occupied the position of General Partner for Brentwood Associates, Director at Odyssey HealthCare, Inc. and Independent Director at Epocrates LLC. Mark Allen Wan received an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.
Adrian Adams Adrian Adams is a businessperson who has been at the helm of 12 different companies and currently is Chairman for AcelRx Pharmaceuticals, Inc., Chairman at Akebia Therapeutics, Inc. and Chief Executive Officer for Aralez Pharmaceuticals Plc. In the past Mr. Adams was Chairman & Chief Executive Officer at Neurologix, Inc., Director at Aralez Pharmaceuticals, Inc. and Chief Executive Officer & Director at POZEN, Inc. (a subsidiary of Aralez Pharmaceuticals, Inc.), Director-Sales & Marketing of ICI Pharmaceuticals, President & Chief Executive Officer of Sunovion Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Inspire Pharmaceuticals, Inc., President & Chief Executive Officer for KOS Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Auxilium Pharmaceuticals LLC, President & Chief Executive Officer for Smithkline Beecham Plc and President & Chief Executive Officer for Novartis Pharmaceuticals UK Ltd. Mr. Adams received an undergraduate degree from The University of Manchester and an undergraduate degree from the University of Salford.
Stephen J. Hoffman Dr. Steve J. Hoffman is a Principal at Skyline Ventures and Chairman at Allos Therapeutics, Inc. He joined Skyline in May 2007. Prior to that, he was a General Partner of TVM Capital, which he joined in January 2003. He was the founding President, Chief Executive Officer and a Director of Allos Therapeutics, Inc., where he is currently Chairman. He is also a director of Sirtris Pharmaceuticals, Inc. Dr. Hoffman received his PhD from Northwestern University in chemistry and his MD from the University of Colorado. Dr. Hoffman completed a fellowship in clinical oncology and a residency and immunodermatology fellowship in dermatology, all at the University of Colorado.
Mark G. Edwards Founder of BioScience Advisors, Inc. and Recombinant Capital, Inc., Mark G. Edwards presently holds the position of Managing Director at BioScience Advisors, Inc. Mr. Edwards is also on the board of AcelRx Pharmaceuticals, Inc. and California Institute for Biomedical Research. In his past career Mark G. Edwards was Managing Director at Recombinant Capital, Inc., Managing Director & Principal at Deloitte Recap LLC and Manager-Business Development at Chiron Corp. He received an MBA and an undergraduate degree from Stanford University.
Vincent J. Angotti Presently, Vincent J. Angotti holds the position of Chief Executive Officer & Director at AcelRx Pharmaceuticals, Inc. In his past career he occupied the position of Chief Executive Officer of XenoPort, Inc., Executive Director-Field Operations at Novartis Pharmaceuticals Corp. and Senior Vice President-Sales & Marketing of Reliant Pharmaceuticals LLC. He received an MBA from Columbia University and an undergraduate degree from Cornell University.
Badri N. Dasu Badri N. Dasu is Member of American Association of Medical Instrumentation, Chief Engineering Officer at AcelRx Pharmaceuticals, Inc. and Member of American Institute of Chemical Engineers. In the past Mr. Dasu held the position of Vice President-Medical Device Engineering at Anesiva, Inc. and Vice President-Manufacturing & Device Development at AlgoRx Pharmaceuticals, Inc. (a subsidiary of Anesiva, Inc.), Director-Process Development at Metrika, Inc., Vice President-Manufacturing & Process Development at Powderject Pharmaceuticals, Inc. and Director-Process Development at Cygnus, Inc. Badri N. Dasu received an undergraduate degree from Mangalore University and a graduate degree from The University of Tulsa.
Richard F. Afable Richard F. Afable is a businessperson who has been at the head of 5 different companies is on the board of California Hospital Association (former Chairman), AcelRx Pharmaceuticals, Inc., Providence Little Co. of Mary Medical Institute and OnSite Waste Technologies, Inc. In the past Dr. Afable occupied the position of President & Chief Executive Officer of St. Joseph Hoag Health, Chief Executive Officer of Covenant Health Network, President & Chief Executive Officer for Hoag Hospital Foundation, Chief Medical Officer & Executive Vice President at Catholic Health East, President & Chief Executive Officer at Hoag Memorial Hospital Presbyterian, Inc., Professor at Wake Forest University and Professor at Northwestern University. Richard F. Afable received a doctorate and an undergraduate degree from Loyola University of Chicago and a graduate degree from the University of Illinois.
Pamela Pierce Palmer Founder of Omeros Corp. and AcelRx Pharmaceuticals, Inc., Pamela Pierce Palmer presently occupies the position of Independent Director & Chief Medical Officer at AcelRx Pharmaceuticals, Inc. Dr. Palmer is also Professor at The University of California, San Francisco. In the past Dr. Palmer was Director-Advanced Research & Education at UCSF Pain Management Center and Director at Omeros Corp. She received a doctorate from Stanford University, a doctorate from Stanford University School of Medicine and an undergraduate degree from the University of Arizona.
Lawrence G. Hamel Lawrence G. Hamel is Chief Development Officer of AcelRx Pharmaceuticals, Inc. In his past career he occupied the position of Vice President & Director-Project Management at ALZA Corp. He received an undergraduate degree from the University of Michigan.
John G. Saia Presently, John G. Saia is Chief Legal Officer of AcelRx Pharmaceuticals, Inc., Secretary & Director at Blue Medical Supply, Inc., Secretary, Director & Vice President at McKesson Automation Systems, Inc. and Secretary, Director & Vice President at McKesson Medical-Surgical, Inc. Mr. Saia is also Secretary, Director & Vice President at McKesson Medical-Surgical Top Holdings, Inc. Mr. Saia previously held the position of Secretary & Associate General Counsel at McKesson Corp. and Principal at DLA Piper LLP (United States). John G. Saia received a graduate degree from George Washington University Law School and an undergraduate degree from Santa Clara University.
Mark A. Evashenk Mark A. Evashenk is Vice President-Clinical Operations at AcelRx Pharmaceuticals, Inc. In his past career he was Director-Clinical Operations at ALZA Corp. He received an undergraduate degree from the University of California, Davis.
Mark G. Edwards Founder of BioScience Advisors, Inc. and Recombinant Capital, Inc., Mark G. Edwards presently holds the position of Managing Director at BioScience Advisors, Inc. Mr. Edwards is also on the board of AcelRx Pharmaceuticals, Inc. and California Institute for Biomedical Research. In his past career Mark G. Edwards was Managing Director at Recombinant Capital, Inc., Managing Director & Principal at Deloitte Recap LLC and Manager-Business Development at Chiron Corp. He received an MBA and an undergraduate degree from Stanford University.
Raffi Asadorian Currently, Raffi Asadorian is Chief Financial & Accounting Officer at AcelRx Pharmaceuticals, Inc. In the past he held the position of Chief Financial Officer for Amyris, Inc., Chief Financial Officer for Unilabs SA, Chief Financial Officer & Senior Vice President of PLIVA dd and Partner at PricewaterhouseCoopers LLP. He received an undergraduate degree from Xavier University and an MBA from Manchester Metropolitan University of.
Richard F. Afable Richard F. Afable is a businessperson who has been the head of 5 different companies. Dr. Afable holds the position of President & Chief Executive Officer of St. Joseph Hoag Health. Dr. Afable is also on the board of California Hospital Association (former Chairman), AcelRx Pharmaceuticals, Inc. and Providence Little Co. of Mary Medical Institute. In the past Dr. Afable was President & Chief Executive Officer for Hoag Hospital Foundation, Chief Executive Officer at Covenant Health Network, Chief Medical Officer & Executive Vice President at Catholic Health East, President & Chief Executive Officer at Hoag Memorial Hospital Presbyterian, Inc., Professor at Northwestern University and Professor at Wake Forest University. Richard F. Afable received a doctorate and an undergraduate degree from Loyola University of Chicago and a graduate degree from the University of Illinois.